Suspension of trading

News Venus Concept Inc.

Stocks

VERO

US92332W3034

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 20:44:37 06/04/2026 +04			5-day change	1st Jan Change
0.3105 ^USD	+2.56%		-0.00%	-79.02%

05-14	Venus Concept Inc. Announces Senior Management Changes	CI
04-09	Venus Concept Inc. announced that it has received $1.5 million in funding	CI

All News

Mentions Relevance

09-10	Venus Concept Inc. Announces CEO Changes	CI
05-14	Venus Concept Announces Senior Management Changes	AQ
05-14	Venus Concept Inc. Announces Senior Management Changes	CI
04-09	Venus Concept Inc. announced that it has received $1.5 million in funding	CI
04-01	Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger	AQ
03-26	Venus Concept Inc. announced that it expects to receive $1.5 million in funding	CI
02-11	Venus Concept Inc.(NasdaqCM:VERO) dropped from S&P TMI Index	CI
02-06	Venus Concept Inc.(OTCPK:VERO) dropped from NASDAQ Composite Index	CI
01-21	Venus Concept announces intention to voluntary delist from Nasdaq and deregister with SEC	RE
01-21	Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC	AQ
01-21	Top Premarket Gainers	MT
01-21	Venus Concept Inc. Announces Voluntary Delisting from NASDAQ and Deregistration with SEC to Enhance Financial Efficiency	CI
01-20	Top Premarket Decliners	MT
01-16	Top Premarket Gainers	MT
01-16	Madryn Asset Management Engages with Venus Concept Inc. on Cost Reduction and Strategic Initiatives Amid Debt Restructuring Efforts	CI
01-08	Venus Concept Inc - On Dec 31, co & its unit enter consent agreement with Madryn Health Partners & others - SEC filing	RE
11-13	Venus Concept Inc., Q3 2025 Earnings Call, Nov 13, 2025
11-13	Venus Concept Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-13	Medical aesthetic device maker Venus Concept's Q3 revenue misses	RE
11-13	Venus Concept: Q3 Earnings Snapshot	AQ
11-13	Venus Concept Announces Third Quarter 2025 Financial Results	AQ
11-10	Venus Concept Gets FDA Clearance to Market Platform for Skin Treatment	MT
11-10	Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments	AQ
11-10	Venus Concept Inc. Receives 510(K) for the Venus NOVA, Its Most Advanced Multi- Application Platform for Non-Invasive Body and Skin Treatments	CI
03/10/25	Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction	AQ